Core Viewpoint - Junyao Health (605388) reported a decline in net profit for the first half of 2025, primarily due to decreased revenue from its traditional ambient yogurt business and increased sales and marketing expenses, alongside higher R&D investments [1] Financial Performance - The company achieved an operating revenue of 766 million yuan in the first half of 2025, representing a year-on-year growth of 1.38% [1] - The net profit attributable to shareholders was 7.4661 million yuan, showing a significant year-on-year decline of 78.52% [1] - Basic earnings per share were reported at 0.0124 yuan [1] Business Challenges - Revenue from the traditional ambient yogurt business decreased compared to the same period last year [1] - Sales and marketing expenses increased significantly compared to the previous year [1] - The company has increased its investment in research and development expenses [1]